02:19

AstraZeneca's $1.5 bn manufacturing facility for antibody drug conjugates (ADCs) in Singapore

02:08

FDA Approves Tarlatamab for Extensive SCLC

05:22

How AI is Revolutionizing Drug Discovery

02:01

Merck KGaA's Investment Boosts AI-powered Biomarker for Personalized Medicine

02:21

EU-Korea Confidentiality Arrangement Explained: Impact on Pharma Regulation

03:08

Diabetes Drugs: HUGE Price Markup Exposed! How Much Should They REALLY Cost?

02:25

New Antibiotic Approved to Fight Serious Bacterial Infections

02:57

FDA Approves First Molecular Test for Malaria in Blood Donations

03:03

Mind-Blowing Tech! Implantable Brain-Computer Interfaces Explained

02:12

AbCellera & Biogen Team Up to Fight Neurological Diseases

02:15

Accu-Chek SmartGuide: The Game-Changing CGM with AI Prediction?

03:02

Follicular Lymphoma Breakthrough! BRUKINSA Gets FDA Nod (For Relapsed Cases)

02:49

Forget ADCs, Enter DACs: Inside Firefly Bio's $94M Revolution

02:07

Pfizer & Saama Team Up for AI-Powered Meds

01:38

Gilead Buys CymaBay for $4.3 Billion - What It Means for Liver Disease

01:38

Narcolepsy Hope: Takeda's TAK-861 Enters Phase 3 Trials!

01:35

Which company is #1 in the Forbes' Best Employers list for Drugs & Biotech in Canada!

03:32

Pharmageddon! Novartis Swallows MorphoSys for €2.7 Billion: Who Wins, Who Loses?

04:09

Aduhelm: A Controversial Journey from Hope to Halt

03:16

Novartis Full Year results 2023! - Sandoz Spin-off, Blockbusters, & Future Outlook

02:58

GSK Soars in FY 2023! But Can They Keep it Up?

02:24

Abecma gets CHMP Green Light for Earlier Multiple Myeloma Treatment

02:58

Dr. Reddy's Laboratories: A Pharmaceutical Powerhouse

03:08

Gene Therapy Brings Hearing Back

01:20

Bausch + Lomb Receives FDA Approval for TENEO Excimer Laser Platform

02:31

2023 FDA Drug Approvals: A Banner Year for Innovation

04:28

AstraZeneca to Acquire Icosavax

03:17

CRISPR Cures Sickle Cell? The Story of Casgevy

03:29

Brain Gain: AbbVie's $8.7 Billion Bet on Cerevel

03:42

Roche's Multi-Billion Dollar Bet on Obesity

02:52

Hope and Fear: A Balancing Act with CAR-T Therapy

02:02

Dr. Reddy’s & Coya Therapeutics collaborate to develop COYA 302 for Amyotrophic Lateral Sclerosis

01:59

Revolutionizing Diabetes Care with Voice AI (Artificial Intelligence)

01:59

Genentech and NVIDIA enter into generative AI research collaboration

01:57

OGSIVEO receives FDA Approval for Desmoid Tumor Treatment!

02:37

AbbVie acquires Immunogen for $10 bn

02:39

November is Prostate Cancer Awareness Month

02:33

Boehringer Ingelheim Bolsters Immuno-Oncology Portfolio with Acquisition of T3 Pharma

01:28

Avistone's Vebreltinib Revolution: MET Exon 14 Approval Sparks New Era in Lung Cancer Care

02:06

Lab-Grown Organs: The Future of Drug Discovery

02:16

US FDA Approves BMS' Augtyro for ROS positive NSCLC

03:40

CRISPR Breakthrough! UK Approves first Gene-Editing Therapy for Sickle-cell & β-thalassaemia

01:52

Pfizer Cuts 500 Jobs in Sandwich UK

01:43

Legend Biotech and Novartis Partner to Develop New Cancer TreatmentLegend Biotech logo

03:45

The Truth About Merck & Co and Merck KGaA

01:48

Bristol Myers Squibb and Tempus enter into collaboration for AI approaches

02:25

Imfinzi (durvalumab) plus bevacizumab met endpoints in EMERALD-1 Phase III results in Liver Cancer

02:47

Demystifying PET Scans: How It's Done | Your Complete Guide

02:48

Understanding PET Scans in Cancer Diagnosis | Medical Imaging Explained

01:51

How Bausch + Lomb's SeeNa Revolutionize Cataract Surgery Planning!

02:09

European Commission Approves KEYTRUDA (pembrolizumab) as Adjuvant Treatment for Adults With NSCLC

02:34

TAGRISSO Plus Chemotherapy Granted Priority Review in the US for Patients with EGFR-Mutated NSCLC

01:48

Cimeio Therapeutics and University of Pennsylvania Collaborate on CD45 CAR T Cell Therapy

02:50

Pfizer's VELSIPITY Granted FDA Approval for Moderate to Severe Active Ulcerative Colitis in Adults

02:08

FDA approves encorafenib + binimetinib for metastatic NSCLC with a BRAF V600E mutation

03:46

Bayer Unveils Pioneering Cell Therapy Hub, Revolutionizing Global Regenerative Medicine

03:13

Bristol Myers Squibb' acquires Mirati Therapeutics

04:05

Breaking News: WHO Backs R21/Matrix-M Vaccine for Malaria Defense in Latest Immunization Guidance

02:44

Breaking Barriers: mRNA-1083 Combats COVID & Influenza | Phase 1/2 Triumph & Gearing Up for Phase 3

02:05

Bausch + Lomb Completes Acquisition of XIIDRA